Canadian Body Calls For Investment In Domestic Production
CGPA Blueprint Also Urges Enhanced International Role And Local Stockpiling
In a new “blueprint” document, the CGPA has called for investment in Canada’s domestic generic pharmaceutical infrastructure to bolster its manufacturing and supply capabilities, as well as urging an enhanced international role and a local stockpile of essential drugs.
